SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Regenerative Medical Technology Group Inc. (RMTG) News

Follow Regenerative Medical Technology Group Inc. (RMTG) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 13 public stories across 12 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol RMTG Asset equity Sector Markets 90 days 11 Last 0.03 Updated Sep 21, 2026, 11:01 AM UTC Open live news feed Open RMTG chart & news
L RMTG - RMTG's ISSCA Division to Host ISSCA 125 Global Summit in Cancún, Mexico RMTG - RMTG's ISSCA Division to Host ISSCA 125 Global Summit in Cancún, Mexico NEWS | Sep 21, 2026, 11:01 AM UTC L Regenerative Medical Technology Group launches ISSCA Integrative Fellowship program Regenerative Medical Technology Group launched an ISSCA Integrative Fellowship in Point-of-Care Regenerative Medicine, positioned as an educational pathway into its early-stage ISSCA AI clinical-intelligence platform. EQUITY | Sep 17, 2026, 11:11 AM UTC L RMTG - RMTG's ISSCA Division Launches Integrative Fellowship in Point-of-Care Regenerative Medicine through ISSCA AI (TM) Strategy RMTG - RMTG's ISSCA Division Launches Integrative Fellowship in Point-of-Care Regenerative Medicine through ISSCA AI (TM) Strategy NEWS | Sep 17, 2026, 11:02 AM UTC L RMTG’s Cellgenic division starts local commercial activity in Colombia RMTG’s Cellgenic division begins local commercial activity in Colombia, subject to Colombian regulatory requirements. EQUITY | Sep 08, 2026, 11:02 AM UTC L RMTG establishes local commercial presence in Brazil RMTG, via Cellgenic, establishes a local commercial presence in Brazil. EQUITY | Sep 03, 2026, 11:01 AM UTC L RMTG’s Cellgenic starts commercial activity in Peru RMTG says its Cellgenic unit has commenced commercial activity in Peru, extending its Latin American footprint. EQUITY | Sep 01, 2026, 11:01 AM UTC L RMTG Cellgenic introduces MUSE cell product line in four regions RMTG says its Cellgenic division introduced the MUSE cell product line across four international regions. EQUITY | Aug 27, 2026, 11:01 AM UTC L RMTG - RMTG Acquires RMTG.com Domain and Launches New Investor-Focused Website, Advancing Shareholder Engagement RMTG - RMTG Acquires RMTG.com Domain and Launches New Investor-Focused Website, Advancing Shareholder Engagement EQUITY | Aug 26, 2026, 11:02 AM UTC L RMTG - RMTG's Cellgenic Division Launches Natural Killer (NK) Cell Product Line for International Markets RMTG - RMTG's Cellgenic Division Launches Natural Killer (NK) Cell Product Line for International Markets EQUITY | Aug 24, 2026, 11:01 AM UTC L RMTG more than quadruples Q2 2026 revenue and gross profit RMTG reports Q2 2026 revenue and gross profit more than quadruple versus Q2 2025, with operating income surpassing $560,000. EARNINGS | Aug 20, 2026, 11:01 AM UTC L RMTG - RMTG Provides Details for First-Ever Investor Call to Answer Shareholder Questions RMTG - RMTG Provides Details for First-Ever Investor Call to Answer Shareholder Questions EQUITY | Aug 19, 2026, 11:25 PM UTC L RMTG expands Cellgenic Cancún lab with two ISO 7 clean rooms RMTG expands Cellgenic’s Cancún laboratory infrastructure by adding two additional ISO 7 clean rooms, according to TradeXchange Newsdesk. EQUITY | Aug 18, 2026, 11:00 AM UTC L RMTG - RMTG to Hold First-Ever Investor Call to Discuss Second Quarter 2026 Results RMTG - RMTG to Hold First-Ever Investor Call to Discuss Second Quarter 2026 Results EARNINGS | Aug 05, 2026, 11:01 AM UTC